MedTrace Logo

Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

NCT06335758 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-03-28

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication.

The study will evaluate and monitor use of ReX in respect of:

* treatment duration
* adverse events
* patient adherence and compliance
* engagement with ReX via patient-reported outcomes

Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

Conditions

  • Any Solid Oral Medication

Interventions

DEVICE

Use of ReX to dispense and monitor solid oral medication therapy.

ReX Remote Digital Nurse comprising hand-held dispenser, disposable drug cartridge and web application (ReX Treatment Manager).

Sponsors & Collaborators

  • US Oncology Research

    collaborator INDUSTRY

  • Dosentrx Ltd.

    lead INDUSTRY

Principal Investigators

  • David Waterhouse, MD · US Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06335758 on ClinicalTrials.gov